| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 07/05/2006 | EP1675831A2 Synthetic method for the preparation of quinazolin-4-one derivatives |
| 07/05/2006 | EP1675593A1 Process for making sterile aripiprazole of desired mean particle size |
| 07/05/2006 | CN1798726A Substituted indoles and a process for preparing substituted indoles |
| 07/05/2006 | CN1798559A Quinoline-2-one-derivatives for the treatment of airways diseases |
| 07/05/2006 | CN1262541C Tricyclic protein kinase inhibitors |
| 07/05/2006 | CN1262540C Bicycle androgen and progesterone receptor modulator compounds and methods |
| 07/04/2006 | US7071337 Anticancer agents |
| 07/04/2006 | US7071290 Block polymers; polyarylenevinylenes |
| 07/04/2006 | US7071210 Mixtures of cholesteryl ester transfer protein (CETP) inhibitor such as torcetrapib and calcium channel blockers, angiotensin converting enzyme inhibitors, diuretics or adrenergic blocking agents use for cardiovascular disorders |
| 07/04/2006 | US7071192 Respiratory system disorders; infections in infants |
| 07/04/2006 | US7071191 Non-imidazole aryloxypiperidines |
| 06/29/2006 | WO2006068617A1 A new manufacturing process for the preparation of halogen substituted 4-hydroxy-2-(2-chloro-4-methylphenyl)-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione |
| 06/29/2006 | WO2006067587A2 Nonnucleoside inhibitors of hiv-1 reverse transcriptase |
| 06/29/2006 | WO2006067472A1 Parp inhibitors |
| 06/29/2006 | WO2006067430A1 2-amino-1-phenylethylcarboxamide derivatives |
| 06/29/2006 | WO2006067414A2 Glycine transport inhibitors |
| 06/29/2006 | WO2006066879A2 Compounds with kv4 ion channel activity |
| 06/29/2006 | US20060142612 Arylsulfonamide derivatives |
| 06/29/2006 | US20060142582 Crystalline forms of pitavastatin calcium |
| 06/29/2006 | US20060142335 Heptyl-carbamic acid 1-benzyl-1, 2, 3, 4-tetrahydro-quinolin-6-yl ester; Alzheimer's disease, senile dementia or memory disturbance |
| 06/29/2006 | US20060142334 Tetrahydroquinoline derivatives |
| 06/29/2006 | US20060142333 e.g. N-(1-Methyl-1,2,3,4-tetrahydroquinolin-7-yl)-1,1'-biphenyl-4-carboxamide; capsaicin recepor antagonist; analgesic; neuropathic, postoperative, postrheumatoid arthritic, back, cancer pain, neuralgia, dental pain, headache, migraine, diabetic and HIV-related neuropathy |
| 06/29/2006 | US20060142300 Anhydrous crystalline forms of I and II of 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methyl-1- piperazinyl) 4-oxo-1, 4-dihydroquinoline-3-carboxylic acid (gatifloxacin) |
| 06/29/2006 | US20060142296 4(Phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 06/29/2006 | US20060142277 Substituted aralkyl derivatives |
| 06/29/2006 | US20060142264 Novel amide derivatives |
| 06/29/2006 | US20060142262 4-[1-(4-Methanesulfonyl-phenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yloxy]-piperidine-1-carboxylic acid tert-butyl ester, for example, as antidiabetic and antiobesity agents |
| 06/29/2006 | CA2592092A1 Nonnucleoside inhibitors of hiv-1 reverse transcriptase |
| 06/29/2006 | CA2587664A1 Compounds with kv4 ion channel activity |
| 06/28/2006 | EP1673346A1 Quinazoline derivatives for the treatment of herpesviral infections |
| 06/28/2006 | EP1673345A1 Derivatives of 3-aminocarbonylquinoline, pharmaceutical compositions containing them and processes and intermediates for their preparation |
| 06/28/2006 | EP1673344A1 1-(quinoline amino) and 1-(isoquinoline amino)-substituted pentan-2-ols, method for their production and their use as anti-inflammatories |
| 06/28/2006 | EP1673343A2 Compounds and compositions as protein kinase inhibitors |
| 06/28/2006 | EP1673090A1 Fused-aryl and heteroaryl derivatives and methods of their use |
| 06/28/2006 | EP1673086A1 4-aminoquinoline-3-carboxamide derivatives as pde4 inhibitors |
| 06/28/2006 | EP1673085A2 C-met modulators and methods of use |
| 06/28/2006 | EP1673084A1 1-2' (1,4'-biperidin-1'-yl)-1-(phenyl)-ethylcyclohexanol derivatives as monoamine reuptake modulators for the treatment of vasomotor symptoms |
| 06/28/2006 | EP1673059A2 Alkanol and cycloalkanol-amine derivatives and methods of their use |
| 06/28/2006 | CN1795177A 1,2,4-substituerte 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity |
| 06/28/2006 | CN1795175A Acetylene derivatives as inhibitors of histone deacetylase |
| 06/28/2006 | CN1261415C Process for preparation of quinoline formaldehyde |
| 06/28/2006 | CN1261099C Tetrahydroquinoline derivatives |
| 06/27/2006 | US7067669 combining 6-hydroxy-3,4-dihydroquinolinone and an alkali metal carbonate; removing water using molecular sieves; adding 1-cyclohexyl-5-(4-halobutyl)-tetrazole; and recovering cilostazol. |
| 06/27/2006 | US7067668 Controlling fungi in plants |
| 06/27/2006 | US7067540 Antiinflammatory agents; antiarthritic agents; antihistamines; sepsis shock; antidiabetic agents; bone disorders |
| 06/27/2006 | US7067539 Cannabinoid receptor ligands |
| 06/27/2006 | US7067533 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof |
| 06/27/2006 | US7067532 Substituted quinolines as antitumor agents |
| 06/27/2006 | US7067530 Compounds may be useful in the treatment and/or prevention of conditions mediated by nuclear receptors, in particular the Peroxisome Proliferator-Activated Receptors (PPAR). The compounds exert their effects by modulating the PPAR gamma |
| 06/27/2006 | US7067517 Use of compounds for decreasing activity of hormone-sensitive lipase |
| 06/27/2006 | US7067506 Compounds useful for inhibiting Chk1 |
| 06/27/2006 | CA2326710C New dihydrofuro-¬3,4-b|quinolein-1-ones derivatives, the procedure for preparing them and the pharmaceutical compositions that contain them |
| 06/27/2006 | CA2238633C Alpha-substituted arylsulphonamido hydroxamic acids as tnf-alpha and matrix metalloproteinase inhibitors |
| 06/22/2006 | WO2006065479A2 Substituted phenols as active agents inhibiting vegf production |
| 06/22/2006 | WO2006064269A2 Salts of leukotriene antagonist montelukast |
| 06/22/2006 | WO2006064179A1 Process and intermediate compounds useful in the preparation of statins |
| 06/22/2006 | WO2006063828A1 4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments |
| 06/22/2006 | WO2006052555A3 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 06/22/2006 | WO2006024741A3 Hybrid qa molecules wherein q is an aminoquinoline and a is an antibiotic residue, their synthesis and their uses as antibacterial agent |
| 06/22/2006 | US20060135812 Thiol-based NAALADase inhibitors |
| 06/22/2006 | US20060135775 Intermediates and process for the production of optically active quinolonecarboxylic acid derivatives |
| 06/22/2006 | US20060135770 PARP inhibitors |
| 06/22/2006 | US20060135532 Anticoagulants; antithrombotic agents in the treatment and prevention of thrombosis |
| 06/22/2006 | US20060135530 Such as (2E)-3-[3-(aminomethyl)-2-isobutyl-4-(4-methylphenyl)quinolin-6-yl]acrylamide; dipeptidyl peptidase IV inhibitors; diabetes, obesity, glucose intolerance |
| 06/22/2006 | DE102004061003A1 New (5'S)-4'-cyclopentyl-3'-((S)-fluoro(4-(trifluormethyl)phenyl)meth yl)-2'-isopropyl-5',8'-dihydro-6'H-spiro(cyclobutane-1,T-quinoline)- 5'-ol is cholesterol transfer protein inhibitor useful for treating e.g. dyslipidemia and stroke |
| 06/22/2006 | DE102004061002A1 New (5'S)-2',4'-dicyclopentyl -3'-9(S)-fluoro(4-(trifluoromethyl) phenyl)methyl)-5',8' -dihydro-6'H-spiro(cyclopropane-1,7'-quinoline)- 5'-ol is a cholesterol ester transfer protein inhibitor useful for treating e.g. coronary heart diseases |
| 06/22/2006 | DE102004061001A1 New spiro-cyclohexyl-pyridine compound is cholesterol ester transfer protein inhibitor useful to treat and/or prevent coronary heart diseases, hypolipoproteinemia, dyslipidemia, hypertriglyceridemia, hyperlipidemia, restenosis and obesity |
| 06/22/2006 | DE102004061000A1 New tetrahydroquinoline compounds are cholesterol ester transfer protein inhibitors useful for primary and/or secondary prevention of coronary heart disease; and for treatment and/or prevention of e.g. hypolipoproteinemia and dyslipidemia |
| 06/22/2006 | DE102004060999A1 New (S)-4-cyclohexyl-3-((S)-fluoro-(4-trifluoromethyl-phenyl)-methyl) -2-isopropyl-7,7-dimethyl-5,6,7,8-tetrahydro-quinolin-5-ol is cholesterol ester transfer protein inhibitor useful e.g. to treat coronary heart disease |
| 06/22/2006 | DE102004060998A1 New 2,4-dicyclopentyl-3-(fluoro-(4-trifluoromethyl-phenyl)-methyl)-7, 7-dimethyl-5,6,7,8-tetrahydro-quinolin-5-ol compound is cholesterol ester transfer protein inhibitor useful to treat and/or prevent e.g. coronary heart diseases |
| 06/22/2006 | DE102004060997A1 New tetrahydroquinoline compounds are cholesterol ester transfer protein inhibitors useful for primary and/or secondary prevention of coronary heart disease; and for treatment and/or prevention of e.g. hypolipoproteinemia and dyslipidemia |
| 06/22/2006 | CA2591397A1 4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments |
| 06/22/2006 | CA2588389A1 Substituted phenols as active agents inhibiting vegf production |
| 06/21/2006 | EP1671950A1 Cinnamoyl derivatives and use thereof |
| 06/21/2006 | EP1671948A1 Cinnamoyl compound and use of the same |
| 06/21/2006 | EP1670788A1 Novel hypocholesterolemic compounds |
| 06/21/2006 | EP1670778A1 Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics |
| 06/21/2006 | EP1670769A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 06/21/2006 | EP1670765A2 Cetp inhibitors and metabolites thereof |
| 06/21/2006 | EP1670473A1 Substituted quinolines as protein tyrosine kinase enzyme inhibitors |
| 06/21/2006 | EP1670458A1 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiphlogistics |
| 06/21/2006 | CN1791607A Chiral ligands and their transition metal complexes |
| 06/21/2006 | CN1791572A Novel compounds |
| 06/21/2006 | CN1789246A Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| 06/20/2006 | US7064209 Reacting 1,3-bis(trimethylsilyloxy)-1-alkoxybuta-1,3-diene with (E)-3-[2-cyclopropyl-4-(4-fluorophenyl)-quinolin-3-yl]-prop-2-en-1-al in presence of optical active binaphthol-titanium complex of a 1,1'-bi-2-naphthol, titanium tetraisopropoxide, metal salt and an amine; desilylation of reaction product |
| 06/20/2006 | US7064208 Substantially pure cilostazol and processes for making same |
| 06/20/2006 | US7064207 Androgen receptor antagonists |
| 06/20/2006 | US7064139 Prevention reproduction of virus |
| 06/20/2006 | US7064134 4-piperidinyl-substituted, e.g., 4-(2-methyl-4-piperidin-1-yl-quinolin-7-ylmethoxy)-benzonitrile; treating eating disorders and obesity |
| 06/20/2006 | US7064133 A 2-carbamoyl-8-hydroxyquinoline-7-carboxylic acid compound or its salt, e.g., 2-(3,4-dihydroxybenzylcarbamoyl)-8-hydroxyquinoline-7-carboxylic acid or its sodium salt, useful as a retrovirus integrase inhibitor, especially for treatment of HIV |
| 06/20/2006 | US7064121 benzodiazepine derivatives that may be fused to a pyrroline or piperidine ring; e.g., N-[1 (R)-(3-Aminopropylcarbamoyl)-2-(naphthalen-2-yl)ethyl]-3-(5,11-dioxo-2,3-dihydro-1H-(11aS)-pyrrolo[2,1-c][1,4]benzodiazepin-10-yl)propionamide; increasing levels of endogenous growth hormones in humans and animals |
| 06/20/2006 | US7064117 Anti-cancer 2,3-dihydro-1H-pyrrolo[3,2-f]quinoline complexes of cobalt and chromium |
| 06/20/2006 | CA2121523C Sulfonamide derivatives |
| 06/15/2006 | WO2006063294A2 Novel inhibitors of histone deacetylase for the treatment of disease |
| 06/15/2006 | WO2006061135A1 Phenyl-piperazin methanone derivatives |
| 06/15/2006 | WO2006010775A8 Tyrosine derivatives as ppar-gamma-modulators |
| 06/15/2006 | WO2005085188A3 Compounds and methods for anti-tumor therapy |
| 06/15/2006 | WO2005058843A8 Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 06/15/2006 | US20060128962 Preparation of quinoline-substituted carbonate and carbamate derivatives |
| 06/15/2006 | US20060128702 Heterocyclic and bicyclic compounds, compositions and methods |